Physician profile
Wallace K Abel
NPI 1003808858
$2,310.13
in general payments reported to CMS, 2019-2025
29 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $413 · 2020: $614 · 2021: $1,228 · 2022: $55.55.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $293.99 | 2019-2021 | |
| Amarin Pharma, INC. | $259.13 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $203.07 | 2019-2021 | |
| Lilly USA, LLC | $190.95 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $136.32 | 2019-2021 | |
| Novo Nordisk INC | $119.34 | 2020-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $100.10 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $94.11 | 2021-2022 | |
| Vanda Pharmaceuticals INC. | $94.00 | 2020 | |
| Dexcom, INC. | $89.27 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $88.58 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $77.72 | 2019-2021 | |
| Amgen INC. | $76.55 | 2019-2022 | |
| Abbvie INC. | $66.96 | 2021 | |
| Boston Scientific Corporation | $65.51 | 2021 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $51.87 | 2020-2021 | |
| Eisai INC. | $48.15 | 2020-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $43.05 | 2020-2021 | |
| Esperion Therapeutics, INC. | $39.19 | 2020-2021 | |
| Sanofi Pasteur INC. | $38.48 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $31.33 | 2021 | |
| Astellas Pharma US INC | $14.78 | 2019 | |
| Jazz Pharmaceuticals INC. | $14.55 | 2019 | |
| Allergan, INC. | $13.90 | 2020 | |
| Assertio Therapeutics, INC. | $12.43 | 2019 | |
| Abbott Laboratories | $11.92 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $11.83 | 2021 | |
| Ironwood Pharmaceuticals, INC | $11.79 | 2019 | |
| Pfizer INC. | $11.26 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wallace Abel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.